Development of a Novel Hematological Malignancy Specific Patient-Reported Outcome Measure (HM-PRO): Content Validity-Reference-Cited by-同舟云学术

Development of a Novel Hematological Malignancy Specific Patient-Reported Outcome Measure (HM-PRO): Content Validity

Published:2020-03-05 Issue: Volume:11 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Goswami Pushpendra,Oliva Esther N.,Ionova Tatyana,Else Roger,Kell Jonathan,Fielding Adele K.,Jennings Daniel M.,Karakantza Marina,Al-Ismail Saad,Collins Graham P.,McConnell Stewart,Langton Catherine,Salek Sam

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference44 articles.

1. Measuring health-related quality of life in leukemia: the functional assessment of cancer therapy–Leukemia (FACT-Leu) questionnaire.;Cella;Value Health,2012

2. An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-MY20) in assessing the quality of life of patients with multiple myeloma.;Cocks;Eur. J. Cancer,2007

3. Pretesting survey instruments: an overview of cognitive methods.;Collins;Qual. Life Res.,2003

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Guidelines for the Use and Reporting of Patient-Reported Outcomes in Multiple Myeloma Clinical Trials;Cancers;2023-12-08

2. Measuring chronic myeloid leukaemia TKI-related toxic effects in the real world: a systematic review and critical assessment of content validity of patient-reported outcome measures;The Lancet Haematology;2023-10

3. Advances in the management of myeloma: an update;British Journal of Nursing;2023-09-21

4. Assessment tools for patient-reported outcomes in multiple myeloma;Supportive Care in Cancer;2023-06-30

5. Systematic Review of the Effect of a One-Day Versus Seven-Day Recall Duration on Patient Reported Outcome Measures (PROMs);The Patient - Patient-Centered Outcomes Research;2023-02-14